Why is Finasteride seen as “scary” for men, but hormonal birth control is totally normalized for women?
    Finasteride/Dutasteride 4/19/2025

    New to Finasteride? There is a guide in the encyclopedia. Read the guide →
    At a glance
    In this general discussion post, the primary subjects mentioned are
    💊 Finasteride (oral) 1mg
    the tone is 😐 neutral.

    Other terms

    Finasteride is seen as risky for men due to side effects like erectile dysfunction, while hormonal birth control for women is normalized despite its side effects. The discussion points out a double standard influenced by societal and gender norms.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research Antiandrogen Therapy for Skin and Hair Disease

      20 citations , April 2006 in “Dermatologic Clinics”
      This review discusses the role of androgen hormones in skin and hair conditions and highlights the potential of antiandrogen therapies in dermatology, reporting no new results.

      research AN OVERVIEW OF MEDICINAL PLANTS USED FOR THE TREATMENT OF HAIR LOSS

      October 2024 in “International Journal of Biology Pharmacy and Allied Sciences”
      In this research, a thorough review of hair loss issues and treatments identified the effectiveness of minoxidil and finasteride for alopecia in the scalp's vertex region, but noted concerns about their potential long-term effects, leading to increased interest in herbal therapies.

      research Androgenetic Alopecia in Gender Minority Patients

      8 citations , November 2019 in “Dermatologic Clinics”
      This study highlights the importance of clinicians understanding the effects of gender-affirming hormones like testosterone, estrogen, and antiandrogens on hair growth, to effectively diagnose and treat androgenetic alopecia in gender minority patients.

      research Androgens and Cardiovascular Disease

      658 citations , June 2003 in “Endocrine reviews”
      This review discusses the role of androgens in the progression of cardiovascular disease and explores novel therapeutic targets without reporting new clinical results.